Basic HTML Version
105
www.chsin.viamedica.pl
Norbert Kwella i wsp.,
Ultrafiltracja pozaustrojowa w leczeniu zaostrzeń przewlekłej niewydolności serca
PIŚMIENNICTWO
1. Adams K.F., Fonarow G.C., Emerman C.L. i wsp. Characteristics and outco-
mes of patients hospitalized for heart failure in the United States: rationale,
design and preliminary observations from 100,0000 cases in the Acute
Decompensated Heart Failure National Registry (ADHERE).
Am. Heart. J.
2005; 149: 209–16.
2. Fang J., Mensah G.A, Croft J.B., Keenan N.L. Heart failure-related hospi-
talization in the U.S., 1979 to 2004.
J. Am. Coll. Cardiol.
2008; 52: 428–434.
3. Hunt S.A., Baker D.W., Chin M.H. i wsp. ACC/AHA guidelines for the eva-
luation and management of chronic heart failure in the adult: executive
summary.
J. Am. Coll. Cardiol
. 2001; 38: 2101–2113.
4. Fonarow G.C., Abraham W.T., Albert N.M. i wsp. Organized Program to
Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure
OPTIMIZE-HF: rationale and design.
Am. Heart J.
2004; 148: 43–51.
5. Patel D.U., Hernandez F.A., Liang L. i wsp. Quality of care and outcomes
among patients with heart failure and chronic kidney disease: A Get With
the Guidelines — Heart Failure Program study.
Am. Heart J.
2008; 156,
4: 674–681.
6. Cleland J.G., Swedberg K., Follath F. i wsp. The EuroHeart Failure survey
programme — a survey on the quality of care among patients with heart
failure in Europe. Part 1: patients characteristics and diagnosis.
Eur. Heart
J.
2003; 24: 442–463.
7. Załuska W. Woda jako toksyna mocznicowa? Forum Nefrologiczne 2010;
3: 12–17.
8. Androne A.S., Katz S.D., Lund L. i wsp. Hemodilution is common in patients
with advanced heart failure.
Circulation
2003; 107: 226–229.
9. Ronco C., Chionh Ch.Y., Haapio M., Anavekar N.S., House A., Bellomo R.
The cardiorenal syndrome.
Blood Purif.
2009; 27: 114–126.
10. Ronco C., Haapio M., House A., Anavekar N.S., Bellomo R. Cardiorenal
syndrome.
J. Am. Coll. Cardiol.
2008; 52: 1527–1539.
11. Silverberg D.S., Wexler D., Iaina A., Steinbruch S., Wollman Y., Schwartz
D. Anemia, chronic renal disease and congestive heart failure- The cardio-
renal anemia syndrome: the need for cooperation between cardiologists
and nephrologists.
Int. Urol. Nephrol.
2006; 38: 295–310.
12. Silverberg D.S., Wexler D., Iaina A. The importance of anemia and its cor-
rection in the management of severe congestive heart failure.
Eur. J. Heart
Fail.
2002; 4: 681–686.
13. Pallazzuoli A., Silverberg D.S., Iovine F. i wsp. Effects of beta-erythropoietin
treatment of left ventricular remodeling, systolic function and B-type na-
triuretic peptide levels in patients with the cardio-renal anemia syndrome.
Am. Heart J.
2007; 154: e9–e15.
14. Münzel T., Mülsch A., Kleschyov A. Editorials: mechanisms underlying
nitroglycerin-induced superoxide production in platelets: some insight,
more questions.
Circulation
2002; 106: 170–172.
15. Jessup M., AbrahamW.T., Casey D.E. i wsp. 2009 Focused Update: ACCF/
/AHA Guidelines for the Diagnosis and Management of Heart Failure in
Adults.
J. Am. Coll. Cardiol
. 2009; 53: 1343–1382.
16. Ellison D.H. Diuretic therapy and resistance in congestive heart failure.
Cardiology
2001; 96: 132–143.
17. KonstamM.A., Gheorghiade M., Burnett J.C. Jr i wsp. Effects of oral tolvap-
tan in patients hospitalized for worsening heart failure: the EVEREST Out-
come Trial.
JAMA
2007; 297: 1319–1331.
18. Kaczmarczyk I., Sułowicz W. Dializa otrzewnowa u chorych z zaawansowaną
niewydolnością serca.
Forum Nefrologiczne
2011; 4: 104–109.
19. Ronco C., Giomarelli P. Current and future role of ultrafiltration in CRS.
Heart
Fail. Rev.
2011; 16: 595–602.
20. Jagodziński P., Lichodziejewska-Niemierko M. Pacjent z oporną na leczenie
niewydolnością serca — opis przypadku i omówienie postępowania.
Forum
Nefrologiczne
2011; 4: 119–123.
21. Khalifeh N., Vychytli A., Hoerl W.H. The role of peritoneal dialysis in the
management of treatment-resistant congestive heart failure: a European
perspective.
Kidney Int. Suppl.
2006; 103: S72–S75.
22. Agostoni P.G., Marenzi G.C., Pepi M. i wsp. Isolated ultrafiltration in moder-
ate congestive heart failure.
J. Am. Coll. Cardiol.
1993; 21: 424–431.
23. Marenzi G.C., Lauri G., Grazi M., Assanelli E., Campodonico J., Agostoni
P.G. Circulatory response to fluid overload removal by extracorporeal ul-
trafiltration in refractory congestive heart failure.
J. Am. Coll. Cardiol.
2001;
38: 963–968.
24. Bart B.A., Boyle A., Bank A.J. i wsp. Ultrafiltration versus usual care for hos-
pitalized patients with heart failure. The Relief for Acutely Fluid-Overloaded
Patients With Decompensated Congestive Heart Failure (RAPID-CHF) Trial.
J. Am. Coll. Cardiol.
2005; 46: 2052–2053.
25. Costanzo M.R., Guglin M.E., Saltzberg M.T. i wsp. Ultrafiltration versus
intravenous diuretics for patients hospitalized for acute decompensated
heart failure.
J. Am. Coll. Cardiol.
2007; 49: 675– 83.
26. Costanzo M.R., Saltzberg M.T., Jessup M. i wsp. Ultrafiltration is associated
with fewer rehospitalisations than continuous diuretic infusion in patients
with decompensated heart failure: results from UNLOAD.
J. Cardiac Fail.
2010; 16: 277–284.
27. Sheppard R., Panyon J., Pohwani A.L. i wsp. Intermittent outpatient ul-
trafiltration for the treatment of severe refractory congestive heart failure.
J. Cardiac Fail.
2004; 10: 380–383.